Novel multifunctional cyclodextrin-based nanocarriers for drug encapsulation and delivery as a strategy to overcome current therapeutic drawbacks

FP7-PEOPLE-ITN-2008 Project No237962, EU funding: a collaboration with nine European partners. 1/10/2009 to 30/09/2013. K. Yannakopoulou, PI and Coordinator.

Budget for the group: 400,000 €

The contribution of the NCSRD group has been the synthesis and study of properties of specially designed cyclodextrins for anticancer drug delivery, nitric oxide release and photodynamic therapy applications (cancer cell lines, ex vivo skin studies), resulting in numerous publications.